IMPORTANT SAFETY INFORMATIONPRESCRIBING INFORMATION

FOLOTYN is indicated for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (R/R PTCL). This indication is based on overall response rate. Clinical benefit such as improvement in progression-free survival or overall survival has not been demonstrated.

Resource Downloads

Download the resources below to help support your patient's FOLOTYN treatment.

Dose Modification Flashcard  

Dose Modification Flashcard

Learn more about dose modifications for treatment-related toxicities, hematologic toxicities, and mucositis.

 
Patient's Guide to FOLOTYN  

Patient's Guide to FOLOTYN

Do your patients have questions about FOLOTYN? This guide can help give them the answers they need.

 
Patient Records and Personal Information Booklet  

Patient Records and Personal Information Booklet

Give your FOLOTYN patients a place to store important treatment-related information.